Research Center for Drug Metabolism, School of Life Science, Jilin University, Changchun 130012, China.
State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun 130012, China.
Molecules. 2023 Jun 15;28(12):4782. doi: 10.3390/molecules28124782.
Polylactic acids (PLAs) are synthetic polymers composed of repeating lactic acid subunits. For their good biocompatibility, PLAs have been approved and widely applied as pharmaceutical excipients and scaffold materials. Liquid chromatography-tandem mass spectrometry is a powerful analytical tool not only for pharmaceutical ingredients but also for pharmaceutical excipients. However, the characterization of PLAs presents particular problems for mass spectrometry techniques. In addition to their high molecular weights and wide polydispersity, multiple charging and various adductions are intrinsic features of electrospray ionization. In the present study, a strategy combining of differential mobility spectrometry (DMS), multiple ion monitoring (MIM) and in-source collision-induced dissociation (in source-CID) has been developed and applied to the characterization and quantitation of PLAs in rat plasma. First, PLAs will be fragmented into characteristic fragment ions under high declustering potential in the ionization source. The specific fragment ions are then screened twice by quadrupoles to ensure a high signal intensity and low interference for mass spectrometry detection. Subsequently, DMS technique has been applied to further reduce the background noise. The appropriately chosen surrogate specific precursor ions could be utilized for the qualitative and quantitative analysis of PLAs, which provided results with the advantages of low endogenous interference, sufficient sensitivity and selectivity for bioassay. The linearity of the method was evaluated over the concentration range 3-100 μg/mL (r = 0.996) for PLA 20,000. The LC-DMS-MIM coupled with in source-CID strategy may contribute to the pharmaceutical studies of PLAs and the possible prospects of other pharmaceutical excipients.
聚乳酸(PLA)是由重复的乳酸单元组成的合成聚合物。由于其良好的生物相容性,PLA 已被批准并广泛用作药物赋形剂和支架材料。液相色谱-串联质谱法不仅是一种强大的分析工具,可用于药物成分分析,也可用于药物赋形剂分析。然而,PLA 的质谱特性分析存在一些特殊问题。除了高分子量和广泛的多分散性外,多电荷和各种加合物是电喷雾电离的固有特征。在本研究中,开发并应用了一种结合差分迁移谱(DMS)、多离子监测(MIM)和源内碰撞诱导解离(in source-CID)的策略,用于 PLA 在大鼠血浆中的特征分析和定量分析。首先,在电离源中采用高离解电位将 PLA 断裂成特征碎片离子。然后,通过四极杆对特定的碎片离子进行两次筛选,以确保质谱检测具有较高的信号强度和较低的干扰。随后,应用 DMS 技术进一步降低背景噪声。选择合适的替代物特异性前体离子可用于 PLA 的定性和定量分析,该方法具有内源性干扰低、生物测定灵敏度和选择性高的优点。该方法在 PLA 20,000 的浓度范围 3-100μg/mL(r=0.996)内具有良好的线性关系。LC-DMS-MIM 与源内 CID 相结合的策略可能有助于 PLA 的药物研究以及其他药物赋形剂的可能前景。